"The Committee noted the innovative approach for using a combination of infrared gas analysis and cavity ring-down spectroscopy and commented on the potential for the proposed technology to set new standards for non-invasive diagnosis of certain disease conditions."
The Phase I AHFMR award will be used to purchase equipment needed for the laboratory prototype of LifeSens.
No comments:
Post a Comment